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believe the decline in the phospholipid/protein ratio seen in
infants receiving bypass is indicative of lung injury. Finally,
by stating that our data support the findings of McGowan and
colleagues,3 we did not mean to imply that we found the same
alteration in surfactant composition that was shown in this
investigation. We were able to demonstrate a quantitative dif-
ference in surfactant, whereas McGowan and associates
showed a qualitative difference, albeit in a different patient
population.
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Complete resection: Yes or no?
To the Editor:
We read with great interest the article titled “Lobe-Specific
Extent of Systematic Lymph Node Dissection for Non–Small
Cell Lung Carcinomas According to a Retrospective Study of
Metastasis and Prognosis” by Asamura and associates (J
Thorac Cardiovasc Surg 1999;117:1102-11). The authors
mentioned that subcarinal lymphadenectomy is not always
necessary for tumors of the right upper lobe and left upper
segment. Their argument is based on the retrospective analy-
sis of their data, which consists of more than 166 cases.
However, we question whether these resections can be classi-
fied as “complete resection.”
The definition of “complete resection” in the management
of non–small cell lung cancer is not uniform in the literature.
The definition provided by Mountain1 has been widely
accepted in the Western world. In this definition, resection
can be considered complete when the highest station sam-
pled at thoracotomy is tumor free and extranodal disease is
not detected in any of the mediastinal nodes. According to
the definition provided by the National Cancer Center in
Japan,2 all the mediastinal stations where tumor can spread
should be removed. Thus more radical node dissection is
required to perform a complete resection according to the
Japanese definition.
Surgical resection can be beneficial only if the resection is
complete. A clearly defined “complete resection” is manda-
tory, not only as a selection criterion for surgery but also for
the postoperative classification of the patients. Otherwise, it
is impossible to detect the positive effect of surgery in the dif-
ferent stages of the disease. We wonder whether Asamura and
associates would consider any resection to be complete with-
out examining all mediastinal nodes.
Asamura and associates argued that subcarinal lymph node
dissection is not necessary for tumors localized to the right
upper lobe and upper division of the left upper segment
because single-station metastases to station 7 are rare. We
wonder how the authors can detect multiple-station metas-
tases, 37% (20/54) of which occur on the right and 50%
(17/34) on the left, without examining all mediastinal sta-
tions. They reported that tumor spread to station 7 was detect-
ed in 12% to 13% of their patients. We think that regardless
of multiple-station or single-station disease, this is too high a
percentage to be neglected. Thus, despite their conclusion,
their data indicate that subcarinal lymphadenectomy should
be performed, which is a relatively easy procedure during
thoracotomy.
A new definition for “complete resection” is urgently need-
ed. We agree with the authors that re-evaluation of the medi-
astinal dissection on the basis of the data collected may be
necessary, but the concept of lung resection for non–small
cell lung cancer should not be changed without the definition
of complete resection being revised. We argue that lung
resection for non–small cell lung cancer without systematic
lymph node dissection should not be performed until a new
definition is provided.
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Reply to the Editor:
We appreciate the interest expressed by Kutlu, Sayar, and
Metin in our consideration of the lobe-specific extent of sys-
tematic lymph node dissection for lung cancer.1 This has been
a point of discussion among thoracic surgeons for a couple of
decades.
Their question can be summarized as follows: Can a pul-
monary resection be regarded as a “complete resection” if
some mediastinal nodes are not examined? Indeed, we have
